Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donatella Boschi

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Chemistry & Biodiversity|May 22, 2010
Nitrooxymethyl-substituted analogues of rofecoxib: synthesis and pharmacological characterizationDonatella Boschi, Clara Cena, Antonella Di Stilo, et al.
Mini Reviews in Medicinal Chemistry|June 11, 2024
Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer AgentsElena Martino, Shruti Thakur, Arun Kumar, et al.
Journal of Mass Spectrometry : JMS|May 24, 2024
Tandem mass spectrometry of homologous 3-hydroxyfurazan and nitrile amino acids: Analysis of cooperative interactions and fragmentation processesJ Stuart Grossert, Andrew M J Crowell, Donatella Boschi, et al.
Molecules (Basel, Switzerland)|June 24, 2022
Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening StudySalvatore Galati, Stefano Sainas, Marta Giorgis, et al.
Chemistry & Biodiversity|March 26, 2009
Nitrooxymethyl-substituted analogues of celecoxib: synthesis and pharmacological characterizationDonatella Boschi, Loretta Lazzarato, Barbara Rolando, et al.
European Journal of Medicinal Chemistry|September 3, 2013
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: a new scaffold endowed with potent CDK2 inhibitory activityDonatella Boschi, Paolo Tosco, Naveen Chandra, et al.
Chemistry & Biodiversity|December 29, 2006
The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activitiesErika Del Grosso, Donatella Boschi, Loretta Lazzarato, et al.
Journal of Medicinal Chemistry|August 9, 2003
New potential uroselective NO-donor alpha1-antagonistsDonatella Boschi, Gian Cesare Tron, Antonella Di Stilo, et al.
FEBS Letters|June 6, 2023
Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitorMarta Alberti, Stefano Sainas, Erika Ronchi, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidantsClara Cena, Donatella Boschi, Gian Cesare Tron, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Chemistry & Biodiversity|May 22, 2010
Nitrooxymethyl-substituted analogues of rofecoxib: synthesis and pharmacological characterizationDonatella Boschi, Clara Cena, Antonella Di Stilo, et al.
Mini Reviews in Medicinal Chemistry|June 11, 2024
Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer AgentsElena Martino, Shruti Thakur, Arun Kumar, et al.
Journal of Mass Spectrometry : JMS|May 24, 2024
Tandem mass spectrometry of homologous 3-hydroxyfurazan and nitrile amino acids: Analysis of cooperative interactions and fragmentation processesJ Stuart Grossert, Andrew M J Crowell, Donatella Boschi, et al.
Molecules (Basel, Switzerland)|June 24, 2022
Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening StudySalvatore Galati, Stefano Sainas, Marta Giorgis, et al.
Chemistry & Biodiversity|March 26, 2009
Nitrooxymethyl-substituted analogues of celecoxib: synthesis and pharmacological characterizationDonatella Boschi, Loretta Lazzarato, Barbara Rolando, et al.
European Journal of Medicinal Chemistry|September 3, 2013
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: a new scaffold endowed with potent CDK2 inhibitory activityDonatella Boschi, Paolo Tosco, Naveen Chandra, et al.
Chemistry & Biodiversity|December 29, 2006
The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activitiesErika Del Grosso, Donatella Boschi, Loretta Lazzarato, et al.
Journal of Medicinal Chemistry|August 9, 2003
New potential uroselective NO-donor alpha1-antagonistsDonatella Boschi, Gian Cesare Tron, Antonella Di Stilo, et al.
FEBS Letters|June 6, 2023
Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitorMarta Alberti, Stefano Sainas, Erika Ronchi, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidantsClara Cena, Donatella Boschi, Gian Cesare Tron, et al.
Pageof 6